Sarcoma Research Studies

< Back to Pediatric Cancer Research Studies Page

Osteosarcoma New Diagnosis

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

  • Ages: ≤ 30 years old

This phase II trial studies the side effects and how well larotrectinib works in treating patients with previously untreated TRK fusion solid tumors and TRK fusion acute leukemia that has come back. Larotrectinib may stop the growth of cancer cells with TRK fusions by blocking the TRK enzymes needed ...More

Contact Us

Contact us.

To learn more about available sarcoma clinical trials, contact us at cancer@cchmc.org or 513-636-2799.